Incomplete UCL injuries in professional baseball players can be successfully treated nonoperatively in the majority of cases. Pitchers are more likely to have complete tears leading to surgery. MRI grading of UCL injuries can help predict RTP and the need for surgery.
Ethium doped BaTiO thin flints for optical waveguide applications were investigated. Characteristic 4f emission at 1560 nm is observed for Er concentrations ranging from 1018 1020 cni3.Faetors which termined the luminescence efficiency were investi and a model for efficiency was developed The luminescence intensity depended predominantly upon two factors: the concentration of radiative Er centers and the de-excitation efficiency of the excited 4f electron state. At a growth temperature of 725°C, the concentration of radiative Er ions was independent of Er dopant concentration. Annealing the thin films in an oxidizing ambient resulted in increased luminescence efficiency whereas annealing under reducing conditions quenched the luminescence.
Objectives:Injury to the elbow ulnar collateral ligament (UCL) is relatively common in pitchers. In the 70's reconstructive surgery was developed as a viable option to a potentially career ending injury. Multiple studies have demonstrated return to play (RTP) rates of 74-83% after reconstruction. Studies of RTP after nonoperative treatment in throwing athletes are limited, reporting 42%. There are no studies reporting RTP rates with nonoperative treatment of professional baseball players. The purpose of this study was to identify professional baseball players' ability to return to play after UCL injuries based on nonoperative vs. operative treatment, MRI grade, and player position.Methods:A retrospective review of a single professional baseball organization (6 minor league teams and 1 Major league team) between 2006 & 2011 revealed 72 medial elbow injuries. MRI was performed on all players. UCL injuries were diagnosed in 45 players by physical exam & MRI. Players were treated with rehabilitation, surgery or both. Success was RTP for >1 season. Rates of RTP and return to the same level of play or higher (RTSP) were calculated and correlated with MRI grade, location, and player position. MRI grading used was: 1 intact ligament +/- edema, 2 partial tearing, 3 complete tear, and 4 chronic healed injury.Results:Overall 91% of 45 players had RTP, and 87% had RTSP. Fifteen were treated surgically and 30 nonoperatively with rehab. Of players treated surgically, 73% had RTSP, whereas 93% of nonoperatively treated players had RTSP (p-value 0.07). All players with grade III tears had surgery. Of surgically treated players, none had grade I injuries, 13% had grade II injuries, 53% had grade III injuries, and 33% had grade IV injuries. Of nonoperatively treated players, 13% had grade I injuries, 23% had grade II injuries, none had grade III injuries, and 60% had grade IV injuries. Of all grade II and grade IV injuries, 78% were treated nonoperatively and all but 1 player in each group (treated nonoperatively) had successful RTSP. Of the players treated for grade III tears, 50% had RTSP, whereas 92% of players treated for incomplete (grades I, II and IV) injuries had RTSP (p-value 0.01), regardless of treatment. When considering RTP rather than RTSP for complete vs. incomplete injuries, the rates improved to 75% and 95% (p-value 0.13) respectively. All grade I injuries, 86% of grade II injuries and 91% of grade IV injuries had RTSP. Of the 45 players with UCL injuries, 33 were pitchers. Among pitchers treated surgically RTP was 86% and RTSP was 71%. Nonoperatively treated pitcher’s RTP and RTSP was the same, 95%. Among the pitchers, 24% had grade III injuries whereas none of the positional players had grade III injuries. Ten of 11 positional players treated nonoperatively had RTSP. One positional player was treated operatively and had RTSP.Conclusion:Professional baseball players treated nonoperatively for UCL injuries have a much higher RTP rate than previously published among throwing athletes. Pitchers are more likely to de...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.